This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


February 24–26, 2020
Loews Philadelphia Hotel,
Philadelphia, PA

Innovative Models for Compliant Patient Support Services to Enhance Access, Affordability and Outcomes

Industry’s largest and highest-acclaimed event focused on Hub and SPP Strategy, providing insight from key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more.

What to Expect

Hub Model Optimization to Streamline and Enhance Processes
  • Hear cutting-edge models delivered by Pharming, Relypsa and Sage Therapeutics
  • Discuss smart launch strategies and leading commercialization frameworks
  • Benefit from a hub blueprint — Product lifecycle action plan and assessment strategies
  • Maximize hub performance through training and staff engagement
  • Ensure safe guardrails for compliance risks associated with patient assistance and reimbursement support
Stakeholder Insights Driving Synergistic Partnerships

Kelley Allison, Vice President of Patient Access, Rare Disease, Horizon Therapeutics

Fran Castellow, MSEd, President, Operations, Patient Advocate Foundation

Raquel Dina, Director, Clinical Affairs and Quality Assurance, Premier Specialty Pharmacy Services

Tom Doyle, Vice President, Commercial Solutions, Eversana

Eric D. Hargan, Deputy Secretary, Department of Health and Human Services (HHS)

Gregg Shapiro, Assistant U.S. Attorney, Chief of Affirmative Civil Enforcement Unit, U.S. Attorney’s Office, District of Massachusetts

Reimbursement and Access Considerations for Innovative Therapies
Spotlight Sessions Include:
  • Novel Therapies in the Digital Frontier — How Will the Hub Adapt and Evolve?
  • Leveraging Next-Gen Tech to Enhance Electronic Benefit Verification and Prior Authorizations to Optimize Workflow
Product-Specific Case Studies Covering:
  • Cell and Gene Therapies
  • Orphan, Rare Disease and Gene Therapies
  • Combination Products